-
Taxonomy & unit
-
us-gaap: GBP
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
TC BioPharm (Holdings) plc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2022 to 2024.
- TC BioPharm (Holdings) plc Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was £933K, a 76.4% decline year-over-year.
- TC BioPharm (Holdings) plc annual Net Cash Provided by (Used in) Financing Activities for 2024 was £11.5M, a 34.6% increase from 2023.
- TC BioPharm (Holdings) plc annual Net Cash Provided by (Used in) Financing Activities for 2023 was £8.52M, a 54.3% decline from 2022.
Net Cash Provided by (Used in) Financing Activities, Quarterly (GBP)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (GBP)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)